Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of black African descent
Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of black African descent
复制标题
DOI:
10.1002/humu.20698
复制
发表时间:
2008-05-01
期刊:
影响因子:
3.9
通讯作者:
Tyndale, Rachel F.
中科院分区:
文献类型:
--
作者:
Mwenifumbo, Jill C.;Al Koudsi, Nael;Tyndale, Rachel F.
Cytochrome P450 2A6 (CYP2A6) is a human enzyme best known for metabolizing tobacco-related compounds, such as nicotine, cotinine (COT), and nitrosamine procarcinogens. CYP2A6 genetic variants have been associated with smoking status, cigarette consumption, and tobacco-related cancers. Our objective was to functionally characterize four nonsynonymous CYP2A6 sequence variants with respect to their haplotype, allele frequency, and association with in vivo CYP2A6 activity. In vivo, nicotine was administered orally to 281 volunteers of Black African descent. Blood samples were collected for kinetic phenotyping and CYP2A6 genotyping. In vitro, nicotine C,oxidation catalytic efficiencies of heterologously expressed variant enzymes were assessed. The four uncharacterized sequence variants were found in seven novel alleles CYP2A6*24A & B, *25, *26, *27, and *28A & B; most were associated with impaired in vivo CYP2A6 activity. Nicotine metabolism groupings, based on the in vivo data of variant alleles, were created. Mean trans-3'-hydroxycotinine/cotinine (3HC/COT) differed (P